|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C12N 15/70 | (2006.01) |
| (11) | Number of the document | 2731973 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12737492.4 |
| Date of filing the European patent application | 2012-07-13 | |
| (97) | Date of publication of the European application | 2014-05-21 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-15 |
| (46) | Date of publication of the claims translation | 2018-02-26 |
| (86) | Number | PCT/EP2012/002945 |
| Date | 2012-07-13 |
| (87) | Number | WO 2013/007388 |
| Date | 2013-01-17 |
| (30) | Number | Date | Country code |
| 11173880 | 2011-07-13 | EP |
| (72) |
ELLIS, Mark, GB
HUMPHREYS, David Paul, GB
|
| (73) |
UCB Biopharma SPRL,
Allée de la Recherche 60, 1070 Brussels,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Bakterijų padermė, ekspresuojanti rekombinantinį DsbC |
| BACTERIAL HOST STRAIN EXPRESSING RECOMBINANT DSBC |
| Payment date | Validity (years) | Amount | |
| 2025-06-04 | 14 | 289.00 EUR |
| 2026-07-13 |